CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-2008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

Cancer Research
Cancer ResearchOncology
2016English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

Current Approaches to Increase CAR T Cell Potency in Solid Tumors: Targeting the Tumor Microenvironment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2019English

Target Selection for CAR-T Therapy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Targeting High-Risk Pediatric Solid Tumors With CAR T Cells Directed Against ALK (Anaplastic Lymphoma Kinase, CD246)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

CAR-T Cells Targeting CLL-1 as an Approach to Treat Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy